Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamiker Biotechnology (Tianjin) CoBJSE:920009 46 Return-on-Tangible-Equity is 10.86% as of Mar. 2026, which is 57% below its 10-year median of 25.25. GuruFocus rates BJSE:920009 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 895 Drug Manufacturers companies, Dynamiker Biotechnology (Tianjin) Co ranks better than 71.28% on this metric.
The historical rank and industry rank for Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity or its related term are showing as below:
BJSE:920009'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.53 Med: 25.25 Max: 49.83
Current: 15.53
During the past 9 years, Dynamiker Biotechnology (Tianjin) Co's highest Return-on-Tangible-Equity was 49.83%. The lowest was 15.53%. And the median was 25.25%.
BJSE:920009's Return-on-Tangible-Equity is ranked better than 71.28% of 895
companies
in the Drug Manufacturers industry
Industry Median: 7.85
vs BJSE:920009: 15.53
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dynamiker Biotechnology (Tianjin) Co Return-on-Tangible-Equity Related Terms
Dynamiker Biotechnology (Tianjin) Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co Return-on-Tangible-Equity Chart
BJSE:920009 vs LLY, JNJ, ABBV: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamiker Biotechnology (Tianjin) Co Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 10.86% mean?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a Return-on-Tangible-Equity of 10.86% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. This is 57% below median its historical median of 25.25. Over the past decade, Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity has ranged from 15.53 to 49.83. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #257 out of 895 companies in the Drug Manufacturers industry, placing it in the top 28.7%.
Is Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity too high?
Dynamiker Biotechnology (Tianjin) Co's current Return-on-Tangible-Equity of 10.86% is 57% below median its 10-year median of 25.25. Over the past 10 years, this metric has ranged from a low of 15.53 to a high of 49.83. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.85. Dynamiker Biotechnology (Tianjin) Co's value of 10.86% is 38.3% above this industry median. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #257 out of 895 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's Return-on-Tangible-Equity compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #257 out of 895 companies for Return-on-Tangible-Equity. This puts Dynamiker Biotechnology (Tianjin) Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.85. Dynamiker Biotechnology (Tianjin) Co's value of 10.86% is 38.3% above this benchmark. Historically, Dynamiker Biotechnology (Tianjin) Co's own Return-on-Tangible-Equity has ranged from 15.53 to 49.83 over the past decade. While the company's 10-year median is 25.25 vs. the industry median of 7.85, Dynamiker Biotechnology (Tianjin) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.85, based on 895 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamiker Biotechnology (Tianjin) Co's current Return-on-Tangible-Equity of 10.86% is 38.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current Return-on-Tangible-Equity is 10.86%, which is 57% below median its own 10-year median of 25.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current Return-on-Tangible-Equity of 10.86%. The current Return-on-Tangible-Equity is 10.86%, which is 57% below median its 10-year median of 25.25 and 38.3% above the Drug Manufacturers industry median of 7.85. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current Return-on-Tangible-Equity is 10.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score
Get the complete analysis for BJSE:920009
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920009 has been successfully added to your 
